Hepion Pharmaceuticals, Inc. (HEPA)
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.
Address
399 THORNALL STREET
EDISON, NJ 08837
Founded
2013
Number of Employees
22
Website
http://www.hepionpharma.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)